Versant Venture AIV Holdings — 2018 Investments
1 investments dated 2018 · listed companies and verified rows first · show all
Second Sight Medical Productsvivani.comNASDAQ: VANIAug 2018SEC filingmedium confidence
Vivani develops miniaturized, long-acting subdermal drug implants using its NanoPortal technology to deliver steady doses of medication over months, addressing medication adherence challenges in chronic disease.
BiotechHealthtechMedical DevicesSylmar, US
ALFRED MANN(Director)ROBERT GREENBERG(Executive Officer, Director)inEdward Sedo(Acting Chief Accounting Officer)Scott Dunbar(Acting CEO)KATHY LONDON(Executive Officer)Adam Mendelsohn(CEO)
Board seatWilliam Link· per SEC Form D · $5M raise · filed Aug 2018
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

